About
Charles Brenner is a biochemist focused on NAD metabolism and nicotinamide riboside, with major academic appointments at City of Hope and, more recently, the University of Helsinki. He serves as Chief Scientific Advisor to Niagen Bioscience and is a co-founder of Alphina Therapeutics. His public profile is that of a scientific and translational longevity/biotech influencer rather than a professional investor.
Areas of interest
longevitybiotechmetabolismNAD biologydiabetescancer metabolismnutritionmetabolomicsneurodevelopmentcoronavirus biology